- Home
- SVRA vs GHY Comparison
SVRA vs GHY Comparison
Compare SVRA & GHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRA | GHY |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 520.5M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRA | GHY |
|---|---|---|
| Price | $5.20 | $11.53 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 134.3K |
| Earning Date | 03-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $430.87 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $11.31 |
| 52 Week High | $7.01 | $13.72 |
Technical Indicators
Market Signals| Indicator | SVRA | GHY |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 21.87 |
| Support Level | $5.10 | N/A |
| Resistance Level | $6.10 | $12.89 |
| Average True Range (ATR) | 0.27 | 0.12 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 38.31 | 6.76 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.